Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RYZ711 PET/CT Imaging in Prostate Cancer
NCT07862582Phase 2Not yet recruiting
- Sponsor
- RayzeBio
- Start
- Oct 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of RYZ711 in prostate cancer (PCa), sponsored by RayzeBio. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
RYZ711
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07862582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07862582.